Figures & data
Figure 1. Isolation of adipose tissue-derived mesenchymal stem cells (AMSCs) and exosomes. (A) The AMSCs surface markers detected by western blots. (B) Representative image of AMSCs. (C) Oil Red O staining in cardiomyocyte administered the adipogenesis treatment. Scale bar = 50 μm. (D) The exosome surface markers detected by western blots. (E) miRNA-320d expression in AMSCs. (F) miRNA-320d expression in exosomes. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).
![Figure 1. Isolation of adipose tissue-derived mesenchymal stem cells (AMSCs) and exosomes. (A) The AMSCs surface markers detected by western blots. (B) Representative image of AMSCs. (C) Oil Red O staining in cardiomyocyte administered the adipogenesis treatment. Scale bar = 50 μm. (D) The exosome surface markers detected by western blots. (E) miRNA-320d expression in AMSCs. (F) miRNA-320d expression in exosomes. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).](/cms/asset/59ded7bd-47d7-475f-b2b2-168cfe7169da/ianb_a_1671432_f0001_c.jpg)
Figure 2. Down-regulation of miR-320d was associated with the regulation of apoptosis and cell viability in cardiomyocytes with AF. (A) Apoptosis level measured by TUNEL staining assays. (B) Apoptosis level measured by Annexin V-FITC/propidium iodide (PI) assays. (C) Cell viability measured by MTT assays. (D) miRNA-320d expression in cardiomyocytes with AF. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).
![Figure 2. Down-regulation of miR-320d was associated with the regulation of apoptosis and cell viability in cardiomyocytes with AF. (A) Apoptosis level measured by TUNEL staining assays. (B) Apoptosis level measured by Annexin V-FITC/propidium iodide (PI) assays. (C) Cell viability measured by MTT assays. (D) miRNA-320d expression in cardiomyocytes with AF. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).](/cms/asset/669caf93-a609-4cb5-9a52-52b268349542/ianb_a_1671432_f0002_c.jpg)
Figure 3. MiR-320d increased in cardiomyocytes co-cultured with modified exosomes. (A) miRNA-320d expression in co-cultured modified exosomes. (B) Apoptosis level measured by TUNEL staining assays. (C) Apoptosis level measured by Annexin V-FITC/propidium iodide (PI) assays. (D) Cell viability measured by MTT assays. (E) Apoptotic protein expressions detected by western blots. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).
![Figure 3. MiR-320d increased in cardiomyocytes co-cultured with modified exosomes. (A) miRNA-320d expression in co-cultured modified exosomes. (B) Apoptosis level measured by TUNEL staining assays. (C) Apoptosis level measured by Annexin V-FITC/propidium iodide (PI) assays. (D) Cell viability measured by MTT assays. (E) Apoptotic protein expressions detected by western blots. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).](/cms/asset/7e3257f7-cfa8-42d9-8f1b-a83ae3c91fad/ianb_a_1671432_f0003_c.jpg)
Figure 4. MiR-320d targeted STAT3 in cardiomyocytes with AF. (A) STAT3 mRNA expression detected by real-time PCR. (B) STAT3 protein expression detected by western blots. (C) The predictive binding sequence of miR-320d in the 3′-UTR of STAT3. (D) Relative luciferase activity. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).
![Figure 4. MiR-320d targeted STAT3 in cardiomyocytes with AF. (A) STAT3 mRNA expression detected by real-time PCR. (B) STAT3 protein expression detected by western blots. (C) The predictive binding sequence of miR-320d in the 3′-UTR of STAT3. (D) Relative luciferase activity. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).](/cms/asset/d19439db-35a6-4ae4-92a1-dcca751f34b8/ianb_a_1671432_f0004_c.jpg)
Figure 5. Down-regulation of STAT3 regulated apoptosis and cell viability in cardiomyocytes with AF. (A) STAT3 mRNA expression detected by real-time PCR. (B) STAT3 protein expression detected by western blots. (C) Apoptosis levels measured by TUNEL staining assays. (D) Apoptosis level measured by Annexin V-FITC/propidium iodide (PI) assays. (E) Cell viability measured by MTT assays. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).
![Figure 5. Down-regulation of STAT3 regulated apoptosis and cell viability in cardiomyocytes with AF. (A) STAT3 mRNA expression detected by real-time PCR. (B) STAT3 protein expression detected by western blots. (C) Apoptosis levels measured by TUNEL staining assays. (D) Apoptosis level measured by Annexin V-FITC/propidium iodide (PI) assays. (E) Cell viability measured by MTT assays. Values are means ± SEM. For each experiment, sample size n ≥ 3. (*) denotes difference from control group (p < .05).](/cms/asset/84c05683-09e3-4731-94b6-e0e5d18c06eb/ianb_a_1671432_f0005_c.jpg)